Prognostic prediction in soft-tissue sarcomas using deep learning and digital pathology of tumor and margin areas
The histological FNCLCC grade is the primary prognostic factor in soft-tissue sarcoma (STS) but fails to fully capture high risk patients. This study aimed to develop and validate a deep learning (DL) model to predict metastatic relapse-free survival (MFS) using digital hematoxylin and eosin-stained whole-slide images. A retrospective analysis was conducted on 308 STS patients from two cancer centers, divided into a training cohort (149 patients) and two independent validation cohorts (64 and 95 patients). Supervised multi-instance learning convolutional neural network models were trained on distinct tumor regions-center (C), periphery (P), and margins (R)-to optimize predictive performance. Univariable analysis showed DL models using tumor center (DL-C), periphery (DL-P), and their combination (DL-CP) were consistently associated with MFS across cohorts, while models incorporating margins (DL-R and DL-CPR) demonstrated less reliable associations. Multivariable Cox regression confirmed that high risk scores from DL models were independent predictors of MFS. The DL-CP model outperformed FNCLCC grading in prognostic accuracy, with c-indices ≥ 0.74 in validation cohorts. Adding tumor margin information did not improve predictions.DL models focusing on tumor center and periphery provide superior prognostic value in STS, offering a streamlined, effective approach for digital pathology-based risk stratification.
Authors
- Carine Ngo (ORCID: https://orcid.org/0000-0002-8172-5876)
- Lucile Vanhersecke (ORCID: https://orcid.org/0000-0001-7733-7806)
- Valérie Velasco
- Mohamed Soussi (ORCID: https://orcid.org/0000-0001-7819-2231)
- Van-Linh Le
- Jean‐Michel Coindre (ORCID: https://orcid.org/0000-0001-8039-6786)
- Amandine Crombé (ORCID: https://orcid.org/0000-0003-0098-6482)
- Sylvie Bonvalot (ORCID: https://orcid.org/0000-0001-9726-9732)
- François Le Loarer (ORCID: https://orcid.org/0000-0001-8582-9819)
- Audrey Michot (ORCID: https://orcid.org/0000-0001-6486-0091)
- Antoîne Italiano (ORCID: https://orcid.org/0000-0002-8540-5351)
- Charles Honoré (ORCID: https://orcid.org/0000-0003-1184-6143)
- Olivier Saut (ORCID: https://orcid.org/0000-0002-4130-150X)
- Maud Toulmonde (ORCID: https://orcid.org/0000-0003-3896-9274)
- Nouria Mesli
- Axel Le Cesne (ORCID: https://orcid.org/0000-0002-8006-8659)
Institutions
- Centre National de la Recherche Scientifique (FR)
- Institut national de recherche en sciences et technologies du numérique (FR)
- Université de Bordeaux (FR)
- Inserm (FR)
- Institut Gustave Roussy (FR)
- Institut Bergonié (FR)
- BoRdeaux Institute of onCology (FR)
- Institut Curie (FR)
Publication Details
- Journal
- Scientific Reports
- Published
- 2025-11-04
- DOI
- https://doi.org/10.1038/s41598-025-20804-1
- Citations
- 1
- Primary Topic
- Sarcoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.52